Taochen He
Zhongshan, 200032, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Gut microbiota and pancreatic cancer: tumorigenesis, progression, and clinical applications.
Journal: Cancer biology & medicine
Published: April 30, 2026
Pathomics Signature for Prognosis and CA19-9 Interception in Pancreatic Ductal Adenocarcinoma: A Real-Life, Multi-Center Study.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: August 19, 2025
CD168 Identifies Proliferating Pancreatic Islet Cells in Murine and Human.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: June 09, 2025
The Evolutionary Trajectory and Prognostic Value of GITR+ Tregs Reprogramed by Tumor-Intrinsic PD-1/c-MET Signaling in Pancreatic Cancer.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: January 13, 2025
The Crosstalk with CXCL10-Rich Tumor-Associated Mast Cells Fuels Pancreatic Cancer Progression and Immune Escape.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: December 29, 2024
Intratumoral IL-33 + CD4 + FoxP3 + regulatory T cell infiltration determines poor clinical outcomes and intensive immunoevasive contexture in patients with pancreatic cancer after surgical resection: a cohort study.
Journal: International journal of surgery (London, England)
Published: November 27, 2024
Poor clinical outcomes and immunoevasive contexture in CD161+CD8+ T cells barren human pancreatic cancer.
Journal: Journal for immunotherapy of cancer
Published: March 15, 2024
Survival benefit and impact of adjuvant chemotherapy following systemic neoadjuvant chemotherapy in patients with resected pancreas ductal adenocarcinoma: a retrospective cohort study.
Journal: International journal of surgery (London, England)
Published: May 11, 2023
Showing 1-10 of 10
Last Updated: 09/26/2026